Global and national initiatives to facilitate studies of vaccines in pregnant women

Clinical Infectious Diseases

Volumn 59, Issue , 2014, Pages S395-S399

  Gruber, Marion F ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Maternal immunization; Pregnancy; Pregnancy labeling; Vaccines

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; GROUP B STREPTOCOCCUS VACCINE; INFLUENZA VACCINE; LIVE VACCINE; PERTUSSIS VACCINE; UNCLASSIFIED DRUG; VACCINE;

2009 H1N1 INFLUENZA; ARTICLE; CONGENITAL MALFORMATION; CYTOMEGALOVIRUS; DRUG SAFETY; ELECTRONIC HEALTH RECORD; FEMALE; FETUS RISK; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNIZATION; LACTATION; LEGAL LIABILITY; OBSTETRIC PROCEDURE; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURITY; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; TETANUS PROPHYLAXIS; CLINICAL TRIAL (TOPIC); HEALTH; INFANT; NEWBORN; PREGNANCY COMPLICATIONS, INFECTIOUS; WORLD HEALTH ORGANIZATION;

CLINICAL TRIALS AS TOPIC; FEMALE; GLOBAL HEALTH; HUMANS; INFANT; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANT WOMEN; VACCINES; WORLD HEALTH ORGANIZATION;

EID: 84937683548     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu707     Document Type: Article

References (30)

1. Miller JK. The prevention of neonatal tetanus by maternal immunization. Wkly Epidemiol Rec 1972; 18:159-67.
2. World Health Organization. Tetanus vaccine position paper. Wkly Epidemiol Rec 2006; 20:197-208.
3. Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices-United States. MMWR Recomm Rep 2013; 62(RR-07):1-43.
4. World Health Organization. Vaccines against influenza WHO position paper-November 2012. Wkly Epidemiol Rec 2012; 87:461-76.
5. Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women-Advisory Committee on Immunization Practices. MMWR Recomm Rep 2013; 62:131-5.
6. Department of Health Government UK. Pregnant women to be offered whooping cough vaccination, 2012. Available at: http://www.dh.gov.uk/health/2012/09/whooping-cough/. Accessed 15 September 2014.
7. Schleiss MR. Prospects for development and potential impact of a vaccine against congenital cytomegalovirus (CMV) infection. J Pediatr 2007; 151:564-70.
8. Kaaijk P, Luytjes W, Rots NY. Vaccination against RSV. Hum Vaccin Immunother 2013; 9:1263-7.
9. Munoz FM, Ferrieri P. Group B Streptococcus vaccination in pregnancy: moving toward a global maternal immunization program. Vaccine 2013; 31:46-51.
10. Wiley KE, Massey PD, Cooper SC, et al. Uptake of influenza vaccine by pregnant women: a cross-sectional survey. Med J. Aust 2013; 198: 373-5.
11. Takayama M, Gillepie CW, Mokdad AH, et al. Health-care access and uptake of influenza vaccination among pregnant women in the USA: a cross sectional survey. The Lancet 2013; 381:S141.
12. World Health Organization. Maternal influenza immunization project: building an immunization platform in conjunction with antenatal care in low and middle-income countries, 2012. Available at: http://www. who.int/immunization/reserach/development/influenza-maternal-immunization. Accessed 12 May 2014.
13. World Health Organization. Meeting of the Strategic Advisory Group of experts on immunization, April 2012-conclusions and recommendations. Wkly Epidemiol Rec 2012; 87:201-16.
14. World Health Organization. Global Advisory Committee on Vaccine Safety, 12-13 June 2013. Wkly Epidemiol Rec 2013; 88:301-12.
15. World Health Organization. Meeting of the Strategic Advisory Group of experts on immunization, November 2013-conclusions and recommendations. Wkly Epidemiol Rec 2014; 89:1-20.
16. Ortiz JR, Neuzil KM, Ahonkhai VI, et al. Translating vaccine policy into action: a report from the Bill & Melinda Gates Foundation consultation on the prevention of maternal and early infant influenza in resourcelimited settings. Vaccine 2012; 30:7134-40.
17. World Health Organization. Global Vaccine Action Plan 2011-2020, 2012. Available at: http://www.who.int/immunization/global-vaccine-Action-plan/GVAP-doc-2011-2020/en/. Accessed 13 May 2014.
18. United Nations Children's Fund. Global Vaccine Action Plan 2011-2020, 2013. Available at: www.unicef.org/immunization/files/Global VaccineActionPlan.pdf. Accessed 15 September 2014.
19. World Health Organization. The Global Vaccine and Immunization Research Forum (GVIRF), 2014. Available at: http://www.who.int/immunization/research/forums-And-initiatives/gvirf/en/. Accessed 15 September 2014.
20. Adegbola R. Immunogenicity and efficacy of influenza immunization during pregnancy: recent and ongoing studies. Am J Obstet Gynecol 2012; 207:S28-32.
21. Fondation Mérieux. Maternal immunization: challenges and opportunities. Available at: http://fondation-merieux.com/maternal-immuni zation. Accessed 13 May 2014.
22. Read JS, Riley L. Progress in overcoming barriers to influenza immunization of pregnant women. Am J Obstet Gynecol 2012; 207(3 suppl): S1-2.
23. National Vaccine Advisory Committee. NVAC Maternal Immunization Working Group Charge, 2012. Available at: http://www.hhs.gov/nvpo/nvac/subgroups/nvac-maternal-immunization-wgcharge.html. Accessed 13 May 2014.
24. Department of Health and Human Services. Solicitation of written comments on the maternal immunization working group's draft report and draft recommendations for reducing patient and provider barriers to maternal immunizations for consideration by the national vaccine advisory committee, 2014. Available at: https://www.federalregister.gov/articles/2014/03/26/2014-06594/solicitation-of-written-comments-onthe-maternal-immunizations-working-groups-draft-report-And-draft. Accessed 13 May 2014.
25. Johri AK. Group B Streptococcus: global incidence and vaccine development. Nat Rev Microbiol 2006; 4:932-42.
26. US Food and Drug Administration. Labeling and prescription drug advertising: content and format for labeling for human prescription drugs. Federal Register. 1979; 44:37434-67.
27. US Food and Drug Administration. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Federal Register. 2008; 73: 30831-68.
28. Mini-Sentinel. Influenza Vaccines and Birth Outcomes Protocol, 2013. Available at: www.mini-sentinel.org/../PRISM/Mini-Sentinel-PRISM-Influenza-Vaccines-And-Birth-Outcomes-Protocol.pdf. Accessed 15 September 2014.
29. Department of Health and Human Services. Study approaches and methods to evaluate the safety of drugs and biological products during pregnancy in the post-Approval setting; public meeting, request for comments. Federal Register 2014; 79:9469-70.
30. Beigi R. Research on vaccines and antimicrobials during pregnancy: challenges and opportunities. Vaccine 2013; 31:4261-3.